The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but ...

Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

Obesity is known to increase the risk of developing many different types of cancer. It’s also associated with worse outcomes in several cancers but improved outcomes in others (in what has been dubbed ...

In this study, researchers investigated long-term outcomes from a real-world cohort of patients with stage IV melanoma treated with pembrolizumab following progression on prior therapies.

New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior ...

Dermatomyositis is an autoimmune inflammatory muscle disease that is linked to cancer in approximately one third of the cases. The most commonly associated cancers are ovarian, lung, gastric, ...

Using less ipilimumab appears to make melanoma immunotherapy both safer and more effective, with dramatically better response and survival outcomes. The findings suggest that reducing side effects may ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced it has completed its ...